MARKET

ENVB

ENVB

Enveric Biosciences Inc
NASDAQ
2.850
-0.320
-10.09%
Pre Market: 2.820 -0.03 -1.05% 04:15 05/11 EDT
OPEN
3.160
PREV CLOSE
3.170
HIGH
3.180
LOW
2.822
VOLUME
1.87K
TURNOVER
0
52 WEEK HIGH
17.84
52 WEEK LOW
1.710
MARKET CAP
5.66M
P/E (TTM)
-0.0786
1D
5D
1M
3M
1Y
5Y
1D
Psychedelic: Jefferies initiates Compass Pathways with a Buy rating
TipRanks · 3d ago
Enveric Biosciences highlights preclinical data for EB-003
TipRanks · 5d ago
ENVERIC BIOSCIENCES INC - REPORTS POSITIVE PRECLINICAL RESULTS FOR EB-003 IN PTSD MODEL
Reuters · 5d ago
Enveric Highlights Preclinical PTSD Data Amid Rising Focus On Mental Health Therapies
Benzinga · 5d ago
Enveric Biosciences Highlights Results for EB-003 In PTSD Preclinical Model; Says Previously Reported Results Support Continued Development Of EB-003 For PTSD, Other Neuropsychiatric Condition
Benzinga · 5d ago
Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model
Barchart · 6d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 6d ago
Weekly Report: what happened at ENVB last week (0427-0501)?
Weekly Report · 6d ago
More
About ENVB
Enveric Biosciences, Inc. is a biotechnology company. The Company is engaged in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. Leveraging its discovery and development platform, the Psybrary platform, which houses proprietary information on the use and development of existing and novel molecules for specific mental health indications, the Company seeks to develop a robust intellectual property portfolio of drug candidates. Its lead molecule, EB-003, is a neuroplastogen designed to promote neuroplasticity, without inducing hallucinations, in patients suffering from difficult-to-address mental health disorders. The Company is focused on advancing EB-003 towards clinical trials for the treatment of neuropsychiatric disorders while out-licensing other Psybrary platform drug candidates to third-party licensees and advancing non-competitive market strategies for patient care.

Webull offers Enveric Biosciences Inc stock information, including NASDAQ: ENVB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENVB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENVB stock methods without spending real money on the virtual paper trading platform.